Topic

Retevmo (selpercatinib)

A collection of 23 issues

How to Get Retevmo (Selpercatinib) Covered by Humana in Georgia: Complete Prior Authorization Guide

Quick Answer: Getting Retevmo Covered by Humana in Georgia Retevmo (selpercatinib) requires prior authorization from Humana for RET fusion-positive cancers. Your fastest path to approval: (1) Confirm RET alteration via FDA-approved testing, (2) Submit PA request through Humana's provider portal with oncologist documentation, and (3) Allow 7-14 days

How to Get Retevmo (Selpercatinib) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Retevmo (selpercatinib) with RET alteration testing via FDA-approved diagnostics like FoundationOne CDx. The fastest path: (1) Gather RET fusion/mutation test results and complete pathology reports, (2) Submit PA through UnitedHealthcare Provider Portal with oncology consultation

Renewing Retevmo (Selpercatinib) Approval with Cigna in Virginia: Complete Renewal Guide and Timeline

Answer Box: Retevmo (Selpercatinib) Renewal with Cigna in Virginia Cigna requires prior authorization renewal for Retevmo (selpercatinib) every 12 months through Express Scripts/Accredo specialty pharmacy. Start your renewal 30-45 days before expiration with updated RET testing confirmation, disease status imaging, treatment response documentation, and an oncologist necessity letter citing

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by Blue Cross Blue Shield in New York Retevmo (selpercatinib) requires prior authorization from Blue Cross Blue Shield in New York for RET fusion-positive NSCLC and RET-mutant thyroid cancers. The fastest path to approval: (1) Confirm RET testing with an FDA-approved companion diagnostic, (2) Submit

How to Get Retevmo (Selpercatinib) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Cigna in Washington Cigna requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and RET-altered thyroid cancers. Key requirements: FDA-approved RET test results, advanced/metastatic disease documentation, and NCCN-aligned medical necessity. If denied, Washington residents can use internal appeals (180-day deadline) followed

How to Get Retevmo (Selpercatinib) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by Humana in New York Retevmo (selpercatinib) requires prior authorization under Humana Medicare plans and may be non-formulary depending on your specific plan. To get coverage in New York: 1) Have your oncologist submit a prior authorization request with RET mutation testing results and medical

Myths vs. Facts: Getting Retevmo (Selpercatinib) Covered by UnitedHealthcare in California

Answer Box: Getting Retevmo Covered by UnitedHealthcare in California The fastest path to Retevmo approval: Submit prior authorization with FDA-approved RET testing results, complete treatment history, and clinical necessity documentation. If denied, file an expedited internal appeal within 21 days, then request California DMHC Independent Medical Review (73% success rate)

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and thyroid cancers. You'll need FDA-approved RET testing results, pathology reports, and clinical documentation. If denied, file internal appeals within 180 days,

How to Get Retevmo (Selpercatinib) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Humana in Illinois Retevmo requires prior authorization from Humana and is typically non-formulary, requiring a formulary exception request. The fastest path to approval: 1) Confirm RET alteration with FDA-approved genetic testing, 2) Have your oncologist submit a comprehensive prior authorization through Humana'

How to Get Retevmo (selpercatinib) Covered by Cigna in Ohio: Complete Prior Authorization and Appeal Guide

Answer Box: Fastest Path to Retevmo Coverage Cigna requires prior authorization for Retevmo (selpercatinib) in Ohio. Your oncologist must submit documentation proving RET gene alteration via FDA-approved testing (like FoundationOne CDx), diagnosis of RET fusion-positive NSCLC or RET-mutant thyroid cancer, and prior treatment history. Submit through Cigna's provider